Otezla 30 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FW8X6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,817
Award facts
- Contract value 100% obligated
- $18,817.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,817.06 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The award represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems.
This delivery order falls within AmerisourceBergen Drug Corp's comprehensive pharmaceutical support vehicle that enables the company to supply a wide range of medications and medical supplies to military healthcare programs worldwide. The underlying IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard. The award of this specific delivery order for Otezla, a dermatological immunosuppressant medication, demonstrates the company's continued role in fulfilling federal medical procurement requirements through DLA's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FW8X6?
SPE2DB25FW8X6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FW8X6 worth?
The government has obligated $18,817 on SPE2DB25FW8X6.
Is contract SPE2DB25FW8X6 an order under another contract?
Yes. SPE2DB25FW8X6 is a delivery order under SPE2DB20D3304, an indefinite delivery contract.
Was contract SPE2DB25FW8X6 competed?
The extent of competition for SPE2DB25FW8X6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award